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Background: Home-based (HB) interventions might facilitate the lifelong uptake of a 
physically active lifestyle following completion of a supervised phase II exercise-
based CR. Yet, data on the long-term effectiveness of HB exercise training on 
physical activity (PA) and exercise capacity (EC) are scarce. 
Objective: The purpose of the TeleRehabilitation in Coronary Heart disease (TRiCH) 
study was to compare the long-term effects of a short HB phase III exercise program 
with telemonitoring guidance to a prolonged center-based (CB) phase III program in 
CAD patients. Primary outcome was exercise capacity. Secondary outcomes 
included PA behaviour, cardiovascular risk profile and health related quality of life.  
Methods: Ninety CAD patients (80 male) were randomized to three months of HB 
(=30), CB (=30) or a control group (CG) (=30) on a 1:1:1 basis after completion of 
their phase II ambulatory CR program. Outcome measures were assessed at 
discharge of the phase II program and after one year.  
Results: Eighty patients [72 (91%) men; mean age 62.6 years] completed the one-
year follow-up measurements. Exercise capacity (VO2P), and secondary outcomes 
were preserved in all three groups (p-time >0.05 for all), irrespective of the 
intervention (p-interaction >0.05 for all). Eighty five percent of patients met the 
international guidelines for PA (p-time < 0.05). No interaction effect was found for 
PA. 
Conclusion: Overall, EC remained stable during one year following phase II CR. Our 
HB exercise intervention was as effective as CB and did not result in higher levels 
of EC and PA compared to the other two interventions. 
Trial registration: ClinicalTrials.gov NCT02047942. 
https://clinicaltrials.gov/ct2/show/NCT02047942 




Cardiac rehabilitation (CR) contributes significantly toward the care of cardiovascular 
disease patients (1), and is nowadays considered as a class IA recommendation by 
all international guidelines (2, 3). CR is a complex multidisciplinary intervention that 
comprises different therapies: i.e. risk factor education and modification, health 
behavior change, psychological support, vocational support and nutritional 
counselling. These interventions target risk factors for coronary artery disease (CAD) 
(4),  and have physical activity (PA) and exercise as their core accounting for 30-
70% of the total programme. Among patients with established CAD, participation in 
an exercise-based CR programme provides major health benefits including reduced 
risk for cardiovascular mortality and hospitalization (and associated health care 
costs) and improvements in health related quality of life (HRQoL) (5).  
Nevertheless, long-term adherence to a healthy active lifestyle remains the biggest 
challenge for these patients (6). Evidence shows that PA levels decline after CR 
completion with as few as 28% of patients maintaining the recommended levels at 
12 months of usual care (7). This is especially worrisome since PA might underlie 
the maintenance of exercise capacity (VO2P) which when compared with other 
known cardiovascular risk factors, is the strongest predictor of mortality among CAD 
patients (8).   
In Belgium, 15-20% of patients participate in an ambulatory CR programme (phase 
II), whereas only 5% participates in a long-term phase III maintenance intervention 
(9). Since it is often easier to integrate an exercise routine into the home and 
community environment (10), the use of home based (HB) CR carries the potential 
to improve compliance to an active lifestyle compared to CB CR in the long-term 
post-hospitalization (10).  
Current technological advances have allowed moving away from the hospital setting 
towards the use of exercise training in the patients’ home. Amongst others, 
telerehabilitation involves the guidance and monitoring of the patient from a distance 
and provision of personalized feedback on a regular base. Earlier meta-analytic data 
already showed that HB rehabilitation could be an alternative for supervised CR for 
promoting maintenance of exercise capacity (EC) in the short-term (11). However, 
the long-term effects of HB have not been widely studied.  Recently Claes et al. (12) 
identified respectively, three and seven studies evaluating PA and exercise capacity 
(EC) at least one year following HB CR (12). Small, though clinically none significant, 
effect sizes for EC were found in favour of home-based CR compared to center-
based CR in the longer-term with similar effects on PA behaviour. Moreover, none 
of these studies used objective tools to assess PA.    
Given the limited data available, the objective of the current report was to compare 
the long-term effects (i.e.one year after completion of an ambulatory phase II CR 
programme) of a 12-week HB program or a 12-week prolonged CB program on EC 
by objectively measuring PA behaviour in CAD patients. We hypothesized that 
patients enrolled in the HB group would show less decrease in peak oxygen 
consumption (VO2P) and higher levels in PA compared to patients in the CB and 
usual care control (CG) group.   
METHODS 
Study design and Population 
The TRiCH study is a randomized controlled clinical trial designed to investigate the 
long-term effect of a HB exercise intervention with telemonitoring guidance on EC, 
PA in CAD patients after discharge from a phase II CR program. A detailed 
description of the experimental design (13), recruitment procedure and eligibility 
criteria as well as the short-term results (14) have been reported elsewhere. The 
study protocol was approved by the medical ethical committee of the UZ Leuven/ KU 
Leuven and all patients provided written informed consent. The TRiCH study was 
registered in ClinicalTrials.gov database: NCT02047942.  
In summary, 90 CAD patients who completed a supervised phase II CR program 
were randomized on a 1:1:1 basis to HB, prolonged CB or a usual care control group 
(CG) for 12-weeks. The HB group received an individualized exercise prescription 
recommending them to exercise for at least 150 minutes a week at a target heart 
rate of 70-80% of heart rate reserve (HRR) at home for 3-months. Patients were 
asked to log all exercise data by means of a Garmin Forerunner (Garmin Forerunner 
210, Wichita USA) and to upload the data on the online web application 
(https://connect.garmin.com/nl-NL/) for review by the investigators (15). Once a 
week, patients received feedback by phone or e-mail.  Patients randomized to CB 
continued their training on an ambulatory base at the outpatient clinic of UZ Leuven. 
This intervention included three weekly sessions, consisting of approximately 45 
minutes of endurance training at 70-80% of HRR followed by relaxation. The CG 
was advised to maintain a physically active lifestyle and was invited for the follow-up 
visits at 12-weeks and 1-year.  Following completion of the 3-months intervention, 
all groups were encouraged to continue exercising. No further contact was provided 
during the subsequent nine months.  
 
Primary outcome meassure 
Cardiorespiratory fitness or exercise capacity. Exercise capacity (EC), was 
determined as VO2P assessed by a maximal graded test on a bicycle until volitional 
exhaustion with breath-by-breath respiratory gas analysis (Ergometrics 800S, 
Ergometrics, Bitz, Baden-Württemberg, Germany) and continuous 12-lead 
electrocardiogram. The test started at 20 W and was increased with 20W/minute. 
We defined VO2P as the 30 seconds average oxygen uptake at the highest workload 
(13). Additionally, we measured peak heart rate, calculated peak respiratory 
exchange ratio and determined both ventilatory thresholds (VT) (13). First ventilatory 
threshold (ventilator anaerobic threshold) was defined as the nadir or first increase 
of ventilation (VE) over oxygen uptake (VO2)  (VE/VO2) versus workload without a 
simultaneous increase in VE over carbon dioxide production (VCO2) (VE/VCO2) 
versus workload. The second ventilatory threshold (respiratory compensation point) 
was defined as the nadir or non-linear increase of VE/VCO2 versus workload’ 
 
Secondary outcome measures 
Physical activity. Physical activity (PA) was measured with a Sensewear® Mini 
Armband (BodyMedia, Inc., Pittsburgh, PA, USA) worn on the non-dominant arm for 
a minimum of five consecutive days. Steps, sedentary time (duration of sedentary 
activity at an intensity of ≤1.5 metabolic equivalents of task [METs]; minutes), 
duration of light intensity physical activity (≥1.5 and ≤3 METs; minutes) and duration 
of moderate and vigorous PA (≥3 METs; minutes) were used in the analyses (16). 
Patients meeting the international guidelines of minimum 150 minutes of moderate 
physical activity or 60 minutes of vigorous activity at the one year follow up were 
labeled as ‘physically active’ (17). 
Muscle function. Sit and rising test (SRT) (18), handgrip strength (JAMAR grip 
strength dynamometer) (19, 20) and quadriceps maximal isometric knee extension 
strength and isokinetic total work (Biodex Medical Systems Inc., 840-000 System 4, 
New York, USA) were also obtained (20).  
Traditional cardiovascular risk factors. We measured traditional cardiovascular 
risk factors including anthropometric characteristics (body mass index, waist and hip 
circumference), blood pressure and biochemical analysis of a fasting blood sample 
(glucose, total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides).  
Health-related quality of life. The SF 36 was used to assess health-related quality 
of life (HRQoL) (13).   
Statistical analysis 
Statistical analyses were performed using SPSS (version 20; SPSS for windows; 
SPSS Inc., Chicago, IL). The current report compares the data obtained at discharge 
of the phase II CR program (= baseline) and after 1-year follow up (FU) between the 
different groups. The Shapiro-Wilk test was used to assess normality of distributions. 
Continuous variables are reported as means ± standard deviation (SD) or median, 
categorical data as numbers and percentages.  One-way analysis of variance 
(ANOVA) and chi-square tests were used to analyse differences in demographic and 
clinical data between groups at baseline. Since we had missing outcome data, we 
applied a linear mixed modelling method was to evaluate time, group and time x 
group interaction effects. Spearman correlation coefficients (p) were calculated 
between VO2P and PA characteristics. A two-tailed P ≤0.05 was considered 
statistically significant. 
RESULTS 
Figure 1 shows the flow of patients throughout the study. In total, 91% or 80 patients 
completed the 1-year FU measurements, while 4 patients (3 men) from the HB 
group, 1 patient from the CB group (1 men) and 5 patients (4 men) from the CG 
group dropped out. At baseline, groups were equal with regard to demographic and 
clinical characteristics, reason for referral and pharmacological treatment (Table 1). 
Demographic characteristics of patients that dropped out were not different from the 
other participants.  
Figure 1. Flow of patients throughout the study. [insert Figure 1.] 
 
Table 1. Baseline characteristics of patients. 
(Continued on next page) 
Characteristics Home-based  
n = 26 
Center-based  
n = 29 
Control  
n = 25 
Age (years) ± SD 62.2 ± 7.1 62.0 ± 7.4 63.7 ± 7.4 
Female (%) 3 (12) 3  (10) 2 (8) 
Reason for referral 
CABG (%) 15 (58) 17 (59) 16 (64) 
PCI (%) 11 (42) 12 (41) 19 (36) 
Cardiovascular risk factors (%) 
Familial predisposition 11 (42) 8 (27) 9 (36) 
Hypertension 10 (38) 10 (34) 13 (52) 
Diabetes 2 (8) 7 (24) 3 (12) 
Table 1. Baseline characteristics of patients. (Continued) 
 
(Continued on next page) 
Characteristics Home-based  
n = 26 
Center-based  
n = 29 
Control  
n = 25 
Dyslipidemia 13 (50) 16 (55) 14 (56) 
Smoking 
Never-smoker 11 (42) 14 (48) 13 (52) 
Ex-smoker 12 (12) 14 (48) 12 (48) 
Current-smoker 3 (46) 1 (4) 0 
Medication 
Anti-hypertensive 19 (73) 26 (90) 19 (76) 
Beta Blockers 17 (65) 22 (76) 20 (80) 
Statins 24 (92) 28 (97) 23 (92) 






Characteristics Home-based  
n = 26 
Center-based  
n = 29 
Control  
n = 25 
Aspirin 24 (92) 27 (93) 24 (96) 
Anti-thrombotic 18 (69) 17 (59) 19 (76) 
Anti-arrhythmic 1 (4) 1 (3) 0 
Hypoglycemic 3 (12) 8 (28) 4 (16) 
Vasodilators 0 1 (3) 2 (8) 
Table 1. Baseline characteristics of patients. Continuous variables are expressed 
as means ± SD, Dichotomous variables are expressed as numbers and 
percentages. CABG, coronary artery bypass graft, PCI, percutaneous coronary 




















Primary outcome measure 
Based on the respiratory exchange ratios (RER) and the BORG score, participants 
in all groups performed a maximal effort at the end of phase II and at 1-year FU 
(Table 2).  Overall VO2P (ml/min/kg) and the maximal test duration remained stable 
over time whatever the group, with subtle though non-significant decreases in the 
CB and CG group. VT1 insignificantly decreased in the CB and CG group, whereas 
it remained stable in the HB.  Difference in responses between groups did however 
not reach statistical significance (P-interaction = >0.05 for all). After 1-year, 12 
patients (46%) from the HB group decreased their VO2P more than 1ml/min/kg, as 


















n = 26 
CB 
n = 29 
Control 
n = 25 
P-Value 
 Baseline 1 Year  Baseline  1 Year  Baseline  1 Year  Time Group Interact. 
VO2 Peak 
(mL•kg−1•min−1) 




2140 ± 599 2227 ± 670 2090 ± 601 2004 ± 508 2300 ± 449 2251 ± 641 0.73 0.32 0.36 
VT1 
(mL•kg−1•min−1) 
19.5 ± 4.9 20.7 ± 6 19.5 ± 6.4 18.7 ± 5.8 20 ± 4.9 19.8 ± 6.3 0.99 0.80 0.13 
VT2 
(mL•kg−1•min−1) 
24.9 ± 5.2 24.8 ± 6.2 22.7 ± 6.9 22.3 ± 6.1 23.8 ± 5.8 24.3 ± 5.4 0.41 0.37 0.62 
          
Table 2. Changes on primary outcome and other respiratory parameters during the study. (Continued) 
 
 




n = 26 
CB 
n = 29 
Control 
n = 25 
P-Value 
Peak HR (bpm) 140 ± 18 142 ± 15 141 ± 21 141 ± 20 140 ± 18 146 ± 20 0.12 0.87 0.47 
Peak RER 1.24 ± 0.8 1.20 ± 0.9 1.23 ± 0.8 1.22 ± 0.8 1.18 ± 0.1 1.21 ± 0.1 0.22 0.48 0.07 
Borg 16 ± 1 15.8 ± 1.2 16.2 ± 1.1 16.1 ± 1.1 15.9 ± 1 16.1 ± 0.9 0.91 0.56 0.42 
Table 2. Changes on primary outcome and other respiratory parameters 
during the study. Data are presented as mean ± SD. Interact, Interaction; VT1, 
First ventilatory threshold; VT2, Second ventilatory threshold; HR, Heart rate; RER, 




Secondary outcome measures  
Figure 3 shows PA data of the groups at the end of CR and at 1-year FU.  Overall, 
96.6% of the population met the international guidelines of 150 minutes or more of 
moderate PA per week at discharge from phase II CR.  At 1-year FU, the number of 
patients fulfilling these guidelines had decreased to 85% (p = 0.1). There were no 
differences across groups (P-group = 0.12). PA, by measurement of average steps 
per day, trended up in HB group from a median of 7896 (2018 - 12554) at baseline 
to 8002 (1612 – 17237) at FU, and down in the other groups although showing no 
significant interaction (P-interaction = 0.75). Although the time spent in light PA 
trended up in the three groups, it showed no significant interaction (P-interaction = 
0.72). The time spent in moderate to vigorous PA, was lower at 12 months of FU 
compared to baseline (P-time = 0.01). However, the decrease was similar in all 
groups (P-interaction = 0.95).   As shown in Table 3, the improvement in isometric 
quadriceps extension, isokinetic total work and handgrip strength reached statistical 
significance (P-time = <0.001) without significant differences among groups (P-
interaction = >0.05).   
Body weight (P-time = .14) increased over time with no change in other measures of 
body composition (Table 4).  Systolic blood pressure remained stable (P-time = 
0.36), whereas a small though significant increase was observed for DBP from 
baseline to FU (P-time = 0.05).  A tendency towards higher total cholesterol and LDL 
values was observed among all three groups (p-time = 0.09 and 0.16 respectively). 
Other CV risk factors did not change significantly at 1-year FU.  Further, there were 
no interactions with the group for any of these parameters (P-interaction = > 0.05 for 
all).   
Finally, all groups maintained high scores for all HRQoL parameters at 1-year FU, 
the interaction in the overall score as well as the subscores were not significant 
between the groups (P-interaction = 0.70) as can be seen in Figure 3. 
 
Figure 3. Daily physical activity at baseline and follow-up. [insert Figure 3.] 
 
Figure 3. Daily physical activity at baseline and follow-up. Data are presented 
as percentage, mean ± SE. Panel A, PA guidelines (>150 min/week); B, Steps/day; 
C, Sedentary behavior = ≤ 1.5 METs; min/day, D: Physical activity duration = 
>3METs; min/day, HB, Home-based group; CB, Center-based group; CG, Control 
group. White column, Baseline; Dark gray column, 1 year FU. 
 
 
Table 3. Changes in strength during the study. 
 HB 
n = 16 
CB 
n = 27 
Control 
n = 18 
P-Value 









151.8 ± 28 168.9 ± 31 150.2 ± 45 157.7 ± 40 148.7 ± 30 163.7 ± 37 0.00 0.72 0.33 
Isokinetic total 
work (J)  
1614 ± 680 1155 ± 272 1758 ± 756 1117 ± 293 1695 ± 796 1142 ± 254 0.00 0.86 0.77 
Sit and Rising 
Test 
7.56 ± 1.8 7.93 ± 1.3 7.44 ± 1.5 7.42 ± 1.3 7.47 ± 1.1 7.30 ± 1.3 0.39 0.53 0.22 
 
Table 3. Changes in strength during the study. Data are presented as mean ± 














Table 4. Cardiovascular risk factors and anthropometrics characteristics during the study. 
 HB  
n = 28 
CB  
n = 30 
Control  
n = 26 
P-Value 
 Baseline 3Month Baseline 3Month Baseline 3Month Time Group Interact 
Anthropometrics          
Weight(kg) 80.4 ± 10 81.5 ± 10 82.9 ± 15 82.9 ± 10 85 ± 12 85.6 ± 12 0.14 0.45 0.51 








101.1 ± 5 101.3 ± 5 103 ± 7.4 102.5 ± 7.8 102.9 ± 4 102 ± 4 0.20 0.60 0.43 
Body fat (Kg) 22.4 ± 4.7 23.5 ± 4.3 24.1 ± 7 24.4 ± 7.6 25.7 ± 6 25.6 ± 5 0.14 0.31 0.25 
Body fat % 26.8 ± 5.7 28.2 ± 4.1 29.5 ± 5 29.1 ± 6.3 29.5 ± 5 29.4 ± 4.7 0.32 0.29 0.06 
(Continued on next page) 
 
Table 4. Cardiovascular risk factors and anthropometrics characteristics during the study (Continued). 
 HB  
n = 28 
CB  
n = 30 
Control  
n = 26 
P-Value 
 Baseline 3Month Baseline 3Month Baseline 3Month Time Group Interact 
Cardiovascular risk factors         
SBP (mmHg) 124.6 ± 15 125.3 ± 15 127.3 ± 15 122.8 ± 15 124.2 ± 13 123.8 ± 17 0.36 0.95 0.32 
DBP (mmHg) 75.4 ± 9.7 77.6 ± 11 75.6 ± 8 74.9 ± 8 76.1 ± 8 80.3 ± 11 0.05 0.44 0.11 
 
Total - C 
(mmol/L) 
 
3.62 ± 0.8  
 
3.75 ± 0.7  
 
3.42 ± 0.6  
 
3.57 ± 0.8 
 
3.35 ± 0.7 
 







HDL - C 
(mmol/L) 
1.38 ± 0.2  1.39 ± 0.3  1.37 ± 0.5  1.38 ± 0.4 1.25 ± 0.3 1.31 ± 0.3 0.47 0.47 0.69 
LDL- C 
(mmol/L) 
1.82 ± 0.7 1.89 ± 0.6 1.57 ± 0.5 1.68 ± 0.6 1.67 ± 0.5 1.73 ± 0.3 0.16 0.23 0.95 
(Continued on next page) 
 
 
Table 4. Cardiovascular risk factors and anthropometrics characteristics during the study (Continued). 
 HB  
n = 28 
CB  
n = 30 
Control  








5.62 ± 0.5 5.36 ± 0.4 5.96 ± 1.0 5.94 ± 1.1 5.56 ± 0.6 5.54 ± 1.0 0.33 0.08 0.33 
HOMA index 1.72 ± 0.7 1.93 ± 1.1 2.32 ± 1.4 2.81 ± 2.4 2.53 ± 1.5 3.18 ± 2.2 0.00 0.05 0.49 
Table 4. Cardiovascular risk factors and anthropometrics characteristics 
during the study. Data are presented as mean ± SD. BMI, Body mass index; SBP, 
Systolic blood pressure; DBP, Diastolic blood pressure; C, Cholesterol; Interact, 
Interaction.  
Figure 5. Changes in HRQoL during the study. [insert Figure 5.] 
Data are presented as percentage, mean ± SE. HB, Home-based group; CB, Center-
























The aim of our study was to compare the longer-term effects of a 12-week HB 
exercise programme with telemonitoring guidance to a prolonged 12-week CB CR 
programme following completion of a phase II CR in patients with CAD. Overall, we 
showed that HB CR is as effective as a prolonged CB CR program to maintain EC 
and PA levels. We also found maintenance of EC and PA at 1-year FU; in fact, 85% 
of our patients met the international guidelines of 150 minutes of moderate PA per 
week (17).  
Contrary to our hypothesis, we could not demonstrate higher levels of PA at 1-year 
FU, in patients randomized to a HB training program with telemonitoring guidance, 
therefore we could not document higher levels of EC compared to the patients 
enrolled to the other groups. 
Yet, our results are in line with the findings of the FIT@Home study (21) in which 90 
low-to-moderate cardiac risk patients initiating a phase II CR program were 
randomized to 3-months of either HB training with telemonitoring guidance or CB 
CR. At 1-year of FU, they reported an improved EC in both groups, without between-
group differences. Our study complements their results since our intervention started 
in phase III CR showing no differences between HB training with telemonitoring 
guidance and CB training in the long-term. Our results also confirm those published 
in a report by Claes et al (12), who showed no influence on EC in HB CR compared 
to usual care when both were offered after completion of a phase II CB CR 
programme.  
These results suggest that although exercise-based CR is often aimed at short-term 
improvement of EC, it might also prepare the patients for independent lifestyle 
changes that favour the long-term maintenance of the benefits obtained at 
completion of a phase II CR programme. 
Frederix et al., published the Telerehab III trial (22, 23), a randomized controlled trial 
(N=140) comparing the efficacy and cost-efficiency of a 24-week telerehabilitation 
programme in addition to conventional CR versus conventional CR alone; patients 
in their intervention were provided with an internet-based telerehabilitation program 
in addition to conventional CB CR. The telerehabilitation program was composed of 
PA telemonitoring, dietary, smoking cessation and activity telecoaching; contrary to 
our intervention, they showed an improvement in EC in favour of the patients 
receiving telerehabilitation. The different outcomes of the studies might be explained 
by the lack of a clear definition for ‘HB CR’. As such, the contents of HB CR 
interventions varied widely and ranged from the use of manuals for a healthier 
lifestyle to personalized exercise prescriptions (12). One such example is the study 
by Park et al (24), who described a positive adherence using an intervention of daily 
text messages (SMS) in combination with a supporting website. The majority of 
participants (85%) in this study reported reading their SMS while the median number 
of visits to the website was only 3 visits in a 6 month period, thus they suggested 
that telemonitoring interventions such as SMS may have a higher likelihood of 
patient participation and adherence than internet-based programs (24). 
Complementary, Coorey et al hypothesized that integrating gamification principles 
into telemonitoring technologies may increase motivation for sustaining essential, 
but repetitive, routine lifestyle tasks over the longer-term (25). 
Cardiac telerehabilitation has been introduced as an adjunct or alternative to 
conventional CR to increase uptake rates, enable more prolonged care, and improve 
long-term success (22). Although we observed a small decrease in the proportion of 
patients meeting the international guidelines for PA, still 85% of patients was doing 
more than 150 minutes of moderate PA 1-year following completion of the phase II 
CR program, which is much more than the 39 to 46% reported in earlier studies (26). 
We speculate that patients underwent a real lifestyle change due to acquired self-
motivation during the CR, though behavioural modifications were not measured in 
our study (16).  However, we cannot rule out the impact of a selection bias whereby 
we potentially have recruited the more motivated patients. Furthermore, the 
awareness of follow-up testing could have motivated patients to maintain their PA 
level (27).  
Cowie et al (28), randomized 60 patients with heart failure to home training, hospital 
training or control.  There were no significant differences in mean steps/day, or 
walking pattern at long-term assessment. They attributed these results to the nature 
of the intervention, which was based on PA alone without behavioral counselling 
similar to our study. Reid et al (29), found a significant decrease in habitual PA during 
long-term FU after hospital discharge in patients with CAD. In the same line, Hansen 
et al (30), found that only 27% of patients participating in CR adhered to the minimal 
PA level required to obtain significant health benefits 18 months after completion of 
a CB CR program. In this TRiCH study, the Sensewear® Mini Armband data showed 
that the PA levels were regular and maintained in the long term for all groups. This 
finding is clinically important since the long-term success of CR rests in part on the 
patient’s ability to maintain healthy behaviors, including participation in regular PA. 
Giannuzzi et al (31), indicated that continued patient interaction and monitoring, as 
well as continuation of a lifestyle intervention (phase III rehabilitation), is required to 
obtain long-term clinical benefits. However, we considered that prolonging the 
supervised exercise intervention for HB or CB groups in our study would not have 
resulted in differences between groups. 
Although numerous studies have illustrated the effects of telemonitoring 
interventions on the incidence of CVD, controversy still remains; a meta-analysis of 
Neubeck et al, has shown significantly favorable changes in total cholesterol, its 
lipoprotein fractions, and smoking habits with telehealth participation compared to 
usual care at medium to long-term follow-up (32). However Gu et al (33), noted that 
several telehealth interventions trials reported non-significant reduction of CVD risk 
factors in patients with prior CAD. Reasons for these different findings could be due 
to difference in sample sizes, follow-up duration, and design of studies centred on 
CV risk factors as primary end point. We considered that the patients included in our 
TRiCH study were at low risk over the first year after enrolment thus the likelihood 
of detecting a beneficial effect was small. Furthermore, the incremental benefit of 
secondary prevention programs over usual care may be very small if the medical 
management of the patients is probably close to optimal (34). 
In relation to HRQoL, Frederix et al (23) evaluated the generic health status through 
the 5Q-5D questionnaire at baseline and at 24 weeks of FU.  They described an 
improvement of QoL in their intervention group derived as result of a reduced 
cardiovascular rehospitalization rate while a deterioration in the control group was 
observed. However, the FIT@home study (21) showed that HRQoL was similar from 
baseline and 1-year FU with no significant between-group differences. Similar to 
their results (21), we were unable to detect changes in HRQoL for either group after 
1-year of FU, in fact, it remained stable during the time of the study, which is 
important as HRQoL seems to have a bi-directional relationship with increased PA 
(16).  
A reduction of 15% to 20% in strength has been reported in every decade after 50 
years of age, leading to deleterious effects on the performance of basic activities of 
daily living (35). Seco et al, described that 26% of adults over the age of 70 could 
not easily climb stairs, 31% had problems carrying a bag weighting 35 kg and 36% 
had walking difficulties.(36) Although no strength differences between the 
interventions were found in our study, there was a significant improvement in 
muscular strength during the follow-up that was not accompanied by improvement 
in muscular endurance. We considered the long-term maintenance of HG and 
quadriceps strength in all participants as a positive result since in older individuals, 
increased muscular strength and endurance tend to reduce disability and to improve 
functional independence and HRQoL (37). Further research regarding muscle 
strength and telerehabilitation interventions are needed in order to confirm our 
results. 
Strengths and limitations 
The present TRiCH study has several strengths. First, we were able to obtained 
objective measures of PA using an accelerometer while previous studies of internet-
based interventions have relied solely on self-reported PA data (38). Second, many 
patients expressed their preference for CB training, however, the randomization 
allowed us to have a proper representation of the CR population in all groups and 
their behaviour in the long-term. Third, although long-term adaptations are the 
ultimate goal of CR (12), the number of studies evaluating the longer-term effects of 
CR interventions are disappointingly low. Thus the TRiCH study with a follow-up 
period of 1-year is one of the few studies that allowed a reasonable time frame to 
assess long-term effects of a telemonitoring program during phase III of CR.  
A limitation in this study is the lack of blinding of test personnel. However, as the 
main outcome measure was PF, the effort of the participants can be compared 
through the respiratory exchange ratio (RER) and the Borg scale (39). The study, as 
do most of randomized controlled trials, had missing outcome data due mainly to 
technical problems or missing numbers in specific tests but these were missing 
completely at random. CR includes important core components such as nutritional 
counselling, risk factor management and psychosocial management; but PA training 
comprises up to >70% of all cardiac rehabilitation activities. Therefore, in this study 
PA tele-monitoring rather than telerehabilitation was assessed (40).  
CONCLUSION 
The results of this TRiCH study show that HB CR and usual care or prolonged CB 
CR are of similar value for maintaining EC, PA anthropometric measures, muscle 
strength and HRQoL in the long term in CAD patients who participated in phase II 
CR. 
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